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Although  zinc (Zn)  deﬁciency  is often  suspected  in  patients  with  taste  disorders,  it may  be  difﬁcult  to
diagnose  Zn  deﬁciency,  especially  in  patients  without  any clear  risk  factors.  Accordingly,  the aim  of  the
present  study  was  to  detect  possible  markers  for taste  disorders  or  zinc  deﬁciency.  To achieve  this  aim,
we  analyzed  data  obtained  from  122  Japanese  men  who  were  not  using  medicines  and had  no  diseases
requiring  treatment.  We  evaluated  the  following  factors:  awareness  of  dysgeusia;  salty  taste  recognition
threshold  (SRT);  the  serum  concentrations  of  Zn,  copper  (Cu),  iron,  alkaline  phosphatase,  and  albumin;u/Zn ratio
ysgeusia
alty taste
and  the  Cu/Zn  ratio.  The  serum  Cu/Zn  ratio  was  positively  correlated  with  the  both  the  SRT  and  the
awareness  of  dysgeusia.  The  serum  Zn concentration  was  not  correlated  with  the SRT  or the  awareness  of
dysgeusia  in  univariate  analyses.  However,  in  multivariate  logistic  regression,  the serum  Zn  concentration
was  associated  with  the  awareness  of  dysgeusia.  In conclusion,  the  serum  Cu/Zn  ratio  is  a good  diagnostic
marker  for taste  disorders  and the value  of 1.1 may  be a  threshold  level for  detecting  taste  disorders.
© 2016  The  Authors.  Published  by  Elsevier  GmbH.  This  is  an  open  access  article  under  the  CC. Introduction
Taste disorders are caused by various factors, and may  develop
n individuals with impairments in any of the organs that connect
he peripheral receptors in the taste buds to the brain or central ner-
ous system. Patients with mental disorders sometimes complain
f subjective dysgeusia as a symptom, and patients with olfactory
isorders may  have ageusia. Therefore, in order to treat taste dis-
rders effectively, it is crucial to identify the cause and then select
n appropriate therapy.
Although zinc (Zn) therapy is effective for patients with taste
isorders or Zn deﬁciency, the efﬁcacy of Zn therapy dose not
ppear to be related to the patient’s serum Zn concentrations [1–6].
ctually, it may  be difﬁcult to diagnose taste disorders associated
ith Zn deﬁciency using serum zinc concentrations alone.
The aim of the current study was to identify possible diagnostic
arkers for taste disorders or Zn deﬁciency. We  evaluated serum
oncentrations of Zn, copper (Cu), iron (Fe), alkaline phosphatase
ALP) and albumin, and the Cu/Zn ratio concomitantly with the
xamination of awareness of dysgeusia and salty taste recogni-
ion threshold (SRT) in 122 subjects. Potential diagnostic markers
∗ Corresponding author.
E-mail address: hryanagisawa@jikei.ac.jp (H. Yanagisawa).
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946-672X/© 2016 The Authors. Published by Elsevier GmbH. This is an open access artic
c-nd/4.0/).BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/).
for taste disorders or Zn deﬁciency were explored by statistically
analyzing the variables examined.
2. Materials and methods
2.1. Subjects
The data used in this study were obtained from the screening
tests of 122 subjects enrolled in a clinical study [7] at the Stomach
and Intestines Department, Kawashima Hospital (Saitama, Japan).
Screening tests were performed between December 12, 2006 and
July 24, 2007, and were divided into 24 series. All of the subjects
were Japanese men  without diseases requiring treatment and
who did not use any drugs at the screening visit. The subjects
were aged from 20 to 50 years (mean ± standard deviation [SD],
28.5 ± 8.3 years; median, 25.0) and their body mass index ranged
from 18.6 to 27.0 kg/m2 (mean ± SD, 22.0 ± 2.0 kg/m2; median,
22.1). The presence or absence of symptoms related to Zn deﬁ-
ciency were not prerequisites for participating in the screening
tests for the ﬁrst 21 subjects. However, the subsequent 101
subjects were enrolled if they had at least one symptom that may
be attributed to Zn deﬁciency (e.g., changes in taste; altered oral
mucosa, scalp hair, or skin; or compromised immunity) to facilitate
the enrollment of subjects with low serum Zn concentrations [7].
le under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-
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Table 1
Salty taste recognition threshold (SRT) values in all subjects and according to the
presence/absence of awareness of dysgeusia.
Group n SRT (mg/cm2) P-value a
All 122 0.60 ± 0.49
Presence 34 0.79 ± 0.61 0.007
Absence 88 0.53 ± 0.41
Values are shown as the mean ± standard deviation.
SRT salty taste recognition threshold.
a t test (presence vs. absence).
Table 2
Results of laboratory tests and reference ranges.
Items Reference range Value Minimum
value
Maximum
value
Zn (g/dL) 64–111 88.9 ± 12.8 57 128
Cu (g/dL) 70–132 88.5 ± 14.4 62 136
Fe (g/dL) 50–200 98.6 ± 42.0 24 280
ALP (IU/L) 110–350 230.8 ± 82.8 101 883
Albumin (g/dL) 3.8–5.3 4.61 ± 0.23 3.8 5.3
Values are shown as the mean ± standard deviation.
Zn zinc, Cu copper, Fe iron, ALP alkaline phosphatase.
Table 3
Correlations among pairs of variables.
Items SRT Zn Cu Fe ALP Albumin
SRT
Zn −0.07
Cu 0.23* 0.00
Fe 0.05 0.02 0.11
ALP 0.04 0.08 0.31** 0.02
Albumin −0.02 0.36** −0.12 0.15 0.00
Cu/Zn ratio 0.21* −0.65** 0.74** 0.09 0.17 −0.34**
SRT salty taste recognition threshold, Zn zinc, Cu copper, Fe iron, ALP alkaline phos-
phatase.H. Yanagisawa et al. / Journal of Trace Elem
.2. Study variables
The following variables were measured in this study: awareness
f dysgeusia, SRT, and serum concentrations of Zn, Cu, Fe, ALP and
lbumin. ALP was chosen as a representative Zn-containing enzyme
nd albumin reﬂects the subject’s nutritional status and binds to
race elements in blood. The Cu/Zn ratio, which was  reported to be
 better indicator of various diseases than Zn or Cu concentrations
lone [8,9], was also determined. The methods used to evaluate
ach variable are described below.
.3. Awareness of dysgeusia
After the subjects completed a questionnaire on taste, they were
nterviewed by an investigator to evaluate whether the subjects
ere aware of dysgeusia. The investigator considered the condi-
ion as being present if the subjects did not confuse dysgeusia with
ysosmia, and they were speciﬁcally aware of dysgeusia, even if
xtent of the symptoms reported by the subjects was not severe.
ll interviews were performed by a single investigator. The taste
uestionnaire was completed before measuring the SRT.
.4. Salty taste recognition threshold
The SRT was assessed using Salsave® (Advantech Toyo Co.,
okyo, Japan) paper strips, which are coated with sodium chloride
NaCl). Although this product was originally developed to support
ietary Na restriction, the results are signiﬁcantly correlated with
aste tests [10]. When used for Na restriction, subjects who  detect
 salty taste at NaCl concentrations of ≤0.6 mg/cm2 are considered
o have a normal taste threshold. Papers were prepared using NaCl
oncentrations of 0, 0.2, 0.4, 0.6, 0.8, 1.0, 1.2, 1.4, and 1.6 mg/cm2.
efore application of each paper strip, subjects gargled natural soft
ater. For each concentration, the subjects put the paper strip on
heir tongue, closed their mouth and licked the paper for 3 s, then
emoved the paper strip from the mouth, and reported whether
hey could taste the salt on the strip. The subjects were ﬁrst given
 blank (0 mg/cm2) paper strip to familiarize themselves with the
aste and texture of the salt-free paper strip without salt. The sub-
ects were then given additional paper strips with increasing NaCl
oncentrations from 0.2 to 1.6 mg/cm2 until they reported a salty
aste. The concentration of NaCl at which the salt taste was  detected
as deﬁned as the recognition threshold. Subjects who  could not
aste salt at the highest concentration (1.6 mg/cm2) were scaled
ut. For the purpose of data analysis, scaled out was deﬁned as a
oncentration of 1.8 mg/cm2.
.5. Measurement of serum Zn, Cu, Fe, ALP, and albumin
oncentrations
All subjects attended the clinic on the morning of the screening
ests after fasting from dinner on the previous day. Blood sam-
les were collected from all subjects between 09:45 and 10:00.
he serum Zn, ALP, and albumin concentrations were measured at
 commercial laboratory using routine clinical laboratory tests. Zn
as measured by atomic absorption spectrometry [11]. Cu and Fe
ere measured by colorimetry in our laboratory.
.6. Statistical analysis
The mean ± standard deviation was calculated for continuous
ariables. Correlations between variables were determined using
earson’s product-moment correlation coefﬁcients. The relation-
hips between the awareness of dysgeusia and individual variables
ere evaluated in terms of odds ratios and 95% conﬁdence intervals,
hich were estimated using logistic regression. Other comparisons* P < 0.05.
** P < 0.01.
were performed using a Fisher’s exact test or Student’s t test as
appropriate. In all analyses, P-values of <0.05 were considered sta-
tistically signiﬁcant.
3. Results
3.1. Subject characteristics
The investigator considered that 34/122 subjects were aware of
dysgeusia, and diagnosed 33 subjects with hypogeusia and 1 sub-
ject with heterogeusia. The mean SRT was 0.60 ± 0.49 mg/cm2 in all
subjects combined, and 8 subjects were scaled out. There were sig-
niﬁcant differences between subjects with awareness of dysgeusia
and subjects without awareness of dysgeusia. The mean SRT in sub-
jects with awareness of dysgeusia was >0.6 mg/cm2, which was  the
upper limit of the normal range for Salsave® (Table 1). The mean
values and reference ranges for the laboratory variables are shown
in Table 2.
3.2. Correlations among laboratory variables and the SRT
The correlations between laboratory variables and the SRT are
presented in Table 3. The serum Cu concentration and the Cu/Zn
ratio were signiﬁcantly and positively correlated with SRT, whereas
the Zn concentration itself was  not correlated with the SRT. The
serum Zn concentration was signiﬁcantly and positively correlated
with the serum albumin concentration.
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Table 4
Univariate logistic regression analysis with awareness of dysgeusia as the outcome
variable.
Explanatory variables Odds ratio (95% conﬁdence interval) P-value
Zn 0.972 (0.941–1.005) 0.091
Cu  1.026 (0.998–1.054) 0.070
Fe  1.005 (0.996–1.015) 0.249
ALP  1.006 (1.000–1.012) 0.061
Albumin 2.345 (0.397–13.847) 0.347
Cu/Zn 8.395 (1.337–52.715) 0.023
Zn zinc, Cu copper, Fe iron, ALP alkaline phosphatase.
Table 5
Multivariate logistic regression analysis with awareness of dysgeusia as the outcome
variable.
Explanatory variables Odds ratio (95% conﬁdence interval) P-value
Zn 0.949 (0.912–0.988) 0.011
Cu  1.024 (0.993–1.057) 0.132
Fe  1.004 (0.994–1.014) 0.446
ALP  1.006 (0.999–1.013) 0.083
Albumin 8.816 (0.966–80.436) 0.054
Zn zinc, Cu copper, Fe iron, ALP alkaline phosphatase.
Table 6
Multivariate logistic regression analysis with zinc and albumin as possible predictors
of  awareness of dysgeusia.
Explanatory variables Odds ratio (95% conﬁdence interval) P-value
Zn 0.960 (0.926–0.996) 0.030
Z
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Table 7
Copper/zinc ratio in subjects divided by the salty taste recognition threshold (SRT).
Groups n Cu/Zn P-valuea
Normal (SRT ≤ 0.6 mg/cm2) 81 0.99 ± 0.21 0.029
Abnormal (SRT > 0.6 mg/cm2) 41 1.08 ± 0.22
Values are shown as the mean ± standard deviation.
Cu copper, Zn zinc, SRT salty taste recognition threshold.
a t test.
Table 8
Proportions of subjects with awareness of dysgeusia according to the copper/zinc
ratio.
Cu/Zn ratio Awareness of dysgeusia P-valuea
Presence Absence
<1.1 18 (21.4%) 66 (78.6%) 0.028
≥1.1 16 (42.1%) 22 (57.9%)Albumin 5.536 (0.764–40.118) 0.090
n zinc.
.3. Logistic regression analysis of awareness of dysgeusia
The presence or absence of awareness of dysgeusia was deﬁned
s the response variable, and the odds ratio and 95% conﬁdence
nterval for each laboratory variable were calculated using simple
ogistic regression (Table 4). In this analysis, only the Cu/Zn ratio
as signiﬁcantly associated with awareness of dysgeusia, because
 higher Cu/Zn ratio was associated with a greater likelihood of
wareness of dysgeusia. The odds ratio and 95% conﬁdence inter-
al were then calculated using a multivariate logistic regression
ncluding all of the variables except for the Cu/Zn ratio (Table 5).
his analysis revealed that lower Zn concentrations were associ-
ted with higher likelihood of awareness of dysgeusia. Additionally,
igher albumin concentrations were associated with a greater like-
ihood of awareness of dysgeusia, opposite to the ﬁnding for Zn,
lthough the association between albumin and awareness of dys-
eusia was not signiﬁcant. Therefore, we repeated the multivariate
ogistic regression analysis using the Zn and albumin concentra-
ions as the explanatory variables (Table 6). In this model, the Zn
oncentration was signiﬁcantly associated with the awareness of
ysgeusia, when adjusting for the serum albumin concentration.
.4. Evaluation of the threshold Cu/Zn ratio
Because the Cu/Zn ratio was associated with subjective symp-
oms and the results of taste tests, the threshold Cu/Zn ratio was
valuated as a possible diagnostic marker. The mean Cu/Zn ratios
n subjects whose SRT was classiﬁed as normal (≤0.6 mg/cm2) or
bnormal (>0.6 mg/cm2) are shown in Table 7. The mean Cu/Zn ratio
as 0.99 in the normal group and 1.08 in the abnormal group, and
he difference between the two groups was statistically signiﬁcant.
ased on these results, the threshold Cu/Zn ratio was  set at 1.1, and
he proportions of subjects with awareness of dysgeusia stratiﬁed
y the Cu/Zn threshold value are shown in Table 8. The propor-Values are shown as the n (%).
Cu copper, Zn zinc.
a Fisher’s exact test.
tion of subjects with awareness of dysgeusia was  signiﬁcantly and
almost two-fold greater in subjects with a Cu/Zn ratio of ≥1.1 as
compared with subjects with a ratio of <1.1 (42.1% vs. 21.4%).
4. Discussion
It has been reported that the Cu/Zn ratio is a good marker for
various diseases [8,9,12,13]. In our study, only the Cu/Zn ratio was
associated with both subjective symptoms and the results of taste
tests (Tables 3 and 4). Although Zn and Cu are known to antag-
onize the absorption of each other and that Zn-containing drugs
are useful for the treatment of Wilson’s disease [14–16], we found
no correlation between serum Zn and Cu concentrations (Table 3).
These results suggest that blood Zn and Cu concentrations vary
considerably among individuals and the balance between these
two elements is more important than their actual concentrations
in the diagnosis of taste disorders and other clinical disorders. In
this study, the serum Cu concentration was signiﬁcantly correlated
with the SRT determined by the taste test. Considering that a prior
study revealed that idiopathic taste disorders were related to Zn
deﬁciency [17], Zn deﬁciency should be highly suspected in indi-
viduals with high serum Cu/Zn ratios, at least in the context of taste
disorders.
The present study demonstrated that the mean serum Cu/Zn
ratio in subjects with a normal SRT in the taste tests was about 1.0
(Table 7), similar to the results of normal control groups in other
studies [18,19]. By contrast, the mean value in subjects with an
abnormal SRT was about 1.1. Although the difference in the Cu/Zn
ratio between these two groups was  small, it was  statistically sig-
niﬁcant (Table 7). When we  used the serum Cu/Zn ratio of 1.1 as
a threshold value, we found a clear difference in the proportion
of subjects with awareness of dysgeusia between subjects with a
ratio of ≥1.1 vs. <1.1 (Table 8). These results suggest that a serum
Cu/Zn ratio of ≥1.1 may  be an effective marker for the diagnosis of
taste disorders derived from Zn deﬁciency. In addition to taste dis-
orders, previous studies revealed the validity of the Cu/Zn ratio for
the severity of nutritional status, inﬂammation, oxidative stress,
immune dysfunction and infection associated with Zn deﬁciency
[9,12,13,18,19]. Therefore, the Cu/Zn ratio appears also to reﬂect
the severity of Zn deﬁciency.
Univariate analyses did not prove that the serum Zn con-
centration was  associated with taste disorders (Tables 3 and 4).
However, multivariate logistic regression analysis revealed that
low serum Zn concentrations were associated with an increased
likelihood of awareness of dysgeusia (Table 5). The serum albumin
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oncentration was positively correlated with the serum Zn con-
entration. Intriguingly, the serum albumin concentration tended
o be associated with increased likelihood of awareness of dys-
eusia (P = 0.054), similar to the association between serum Zn
nd awareness of dysgeusia (Tables 3 and 5). A previous study
uggested that normalization of serum Zn concentrations against
erum albumin concentrations using an adjusted Zn formula was an
vailable means to predict taste disorders [20]. Thus, serum albu-
in  concentrations should be measured together with serum Zn
oncentrations in patients with taste disorders.
In conclusion, the serum Cu/Zn ratio was a good marker for taste
isorders and our results suggest that a value of 1.1 is a potential
hreshold level for the diagnosis of taste disorders. To justify the
alidity of the Cu/Zn ratio, it will be necessary to assess the rela-
ionships between the serum Cu/Zn ratio and taste disorders before
nd after Zn replacement therapy.
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